Published • loading... • Updated
Abstract: One Biosciences Announces Data on a New Method for Constructing Transcriptomic Tumor Profiles Based on Individual Cells From Clinicopathological Samples.
Summary by Business Wire
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PARIS--(BUSINESS WIRE)--One Biosciences, a techbio company pioneering clinical-grade single-cell tumor profiling, today announced data demonstrating that single-cell RNA expression profiles can be generated from standard formalin-fixed and paraffin-embedded (FFPE) pathological samples obtained in routine cancer care using the company's proprietary platform, OneMap™. The research we
·Crystal River, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
